T3 Pharma wins the Swiss Economic Forum award 2021

T3 Pharmaceuticals AG – a biotech company focused on immuno-oncology – wins the SEF award 2021 in the category High-tech/Biotech.

In a multi-step selection process and among 107 applicants the distinguished jury has bestowed T3 Pharma with the SEF award 2021. «We are honored to receive such a prestigious price from the Swiss Economic Forum», commented Simon Ittig, CEO of T3 Pharma. «We would like to thank the jury for recognizing the potential of our bacteria-based cancer therapy and our work. On this day of celebration our thanks go to everyone who accepted challenges and risks together with us along the journey, which we are thrilled to continue